SEC Comment Letter for MedAvail Holdings, Inc. (MDVLQ) (CIK 0001402479) — Apr 27, 2020
MedAvail Holdings, Inc. (MDVLQ) (CIK 0001402479)
Date: April 27, 2020 · CIK: 0001402479 · Accession: 0000000000-20-003562
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237757
Letter
United States securities and exchange commission logo April 27, 2020 Joseph Mannello Chief Executive Officer MYOS RENS Technology Inc. 45 Horsehill Road, Suite 106 Cedar Knolls, NJ 07927 Re:MYOS RENS Technology Inc. Registration Statement on Form S-3 Filed April 20, 2020 File No. 333-237757 Dear Mr. Mannello: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Joshua N. Englard, Esq.
Show Raw Text
United States securities and exchange commission logo
April 27, 2020
Joseph Mannello
Chief Executive Officer
MYOS RENS Technology Inc.
45 Horsehill Road, Suite 106
Cedar Knolls, NJ 07927
Re:MYOS RENS Technology Inc.
Registration Statement on Form S-3
Filed April 20, 2020
File No. 333-237757
Dear Mr. Mannello:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Joshua N. Englard, Esq.